Biopharmaceuticals Market Reports

Biopharmaceuticals and vaccines are produced using live cell cultures or cell components. Also known as biologics, biopharmaceuticals are therapeutic agents such as antibodies, proteins, peptides and hormones produced by living cells in industrial operations. Kalorama Information reports provide specifics on biopharmaceuticals and bioproduction markets including market share, segmentation, size, and growth in the United States and globally.

loading... Loading...
Published: | Price: {{result.PriceString}}
...

No reports match your search criteria.


RSS Subscription
{{ pageDetailsDisplay }}
Published: Aug 29, 2014 | Price: $3,995.00
Biopharmaceutical and Vaccine Production Markets Biopharmaceutical and Vaccine Production Markets analyzes the entire manufacturing market for biologic drugs, including both outsourcing and costs by major maufacturers spending internally on biopharmaceutical and vaccine production.As part of its...
Published: Sep 22, 2013 | Price: $2,995.00
The World Market for Biosimlars (EPO, G-CSF, HGH, Insulin, Interferon Alpha, Monoclonal Antibodies, Other), 4th Edition This study, The World Market for Biosimilars, 4th Edition (EPO, G-CSF, HGH, Insulin, Interferon alpha, mAbs, Others), is designed to provide a comprehensive look at the various...
Published: Oct 15, 2011 | Price: $3,500.00
Several cell culture-derived biopharmaceutical drugs were launched in the US and European markets in 2010. Biopharmaceuticals (recombinant proteins, monoclonal antibody and nucleic acid-based products) represent the fastest growing sector in the pharmaceutical industry. Driving the extraordinary...
Published: Jul 1, 2011 | Price: $2,995.00
As researchers work to improve drug properties through drug design and molecular modeling, the line between drug delivery and drug substance will become more and more elusive in the near future, as shown in the analysis in this report. Consequently, in the next decade, drug delivery technologies...
Published: May 1, 2011 | Price: $2,995.00
The future of the pharmaceutical market will be determined by biologics - drugs produced by natural organisms or recombinant techniques consisting of proteins and other products derived from living organisms for the treatment or management of diseases or injuries. What are the products that lead...
Published: Jul 1, 2010 | Price: $995.00
What Will The Pharmaceutical Market Look Like in the Next Five Years? In this report, Kalorama has analyzed the late stage R&D pipeline of the 50 top companies in pharmaceuticals -- the companies that produce the lion's share of industry revenues. While the report looks at the entire pipeline...
Published: Sep 1, 2009 | Price: $2,995.00
With pharmaceutical companies increasingly looking for ways to extend the revenue-earning lifetime of their biggest products, drug delivery has become an important focus of the industry. Kalorama’s Drug Delivery Markets: Implantable / Injectable and Needle-Free Delivery Systems provides...
Published: May 1, 2009 | Price: $2,995.00
Cell culture is a major foundation of biopharmaceutical development, bioprocessing and manufacturing. As the biopharmaceutical market grows, so should interest in the cell culture products market. Biopharmaceutical products are developed from large, complex protein molecules, which require equally...
Published: May 1, 2009 | Price: $995.00
Worldwide cancer affects more than 10 million people each year. This number is expected to increase by 2.4% by 2020 to 14 million each year. Worldwide approximately 22 million people are living with cancer and nearly 7 million people die. The most common cancers affecting the world include lung,...
Published: Feb 1, 2009 | Price: $995.00
Political and business events presage change for stem cell therapeutics, most notably the expected move by President Barack Obama to lift federal funding restrictions on stem-cell research. The U.S. Congress has also indicated a desire to move forward with stem cell research. The momentum in two...
Published: Jan 1, 2009 | Price: $995.00
This report is focused on two expanding pharmaceutical outsourcing markets, contract manufacturing of prescription drugs and contract sales and marketing. Both markets represent excellent post launch outsourcing opportunities for companies competing in this fast growing pharmaceutical outsourcing...
Published: Apr 1, 2008 | Price: $995.00
In one sense, the opportunity for follow-on proteins is as good as ever. Some of the biggest-selling biologics developed during the first phase of the biotechnology revolution in the 1980s, including human growth hormone (hGH) and insulin, have lost patent protection or are set to lose patent...
Published: Mar 1, 2008 | Price: $995.00
With their ability to differentiate and become an ongoing source of cells that make up critical tissues and organs, stem cells have potential for new regenerative therapies and as new research tools for drug developers to test emerging therapies on diseased cells. For market-watchers in the...
Published: May 1, 2007 | Price: $995.00
Cancer is the second most common cause of death in the industrialized world. At this time, treatment for cancer focuses on some combination of surgery, radiation, and chemotherapy. But over the next five years, treatment is going to dramatically change. as detailed in the report Monoclonal...
Published: Jan 1, 2007 | Price: $4,300.00
As the biopharmaceutical market grows, so will the cell culture products market. Cell culture is a major foundation of biopharmaceutical development, bioprocessing and manufacturing. Biopharmaceutical products are developed from large, complex protein molecules, which require equally complex...
Published: Sep 1, 2006 | Price: $3,900.00
This report is focused on two expanding pharmaceutical outsourcing markets, contract manufacturing and contract sales and marketing. Both markets represent excellent post launch outsourcing opportunities for companies competing in this fast growing pharmaceutical outsourcing sector. The report...
Published: Jun 1, 2006 | Price: $995.00
The protein therapeutics sector is a story of triumphant science, representing both life-saving treatments for millions and a multi-billion dollar industry. This report details both the scientific and business aspects of the protein therapeutics marketplace, including market size and growth,...
Published: Jan 1, 2006 | Price: $995.00
With the mapping of the human genome and the concomitant explosion of proteomics, a steady stream of biopharmaceuticals have been launched—recombinant therapeutic proteins, monoclonal antibody-based products used for therapeutic or in vivo diagnostic purposes, and nucleic acid-based products....
Published: Nov 1, 2005 | Price: $2,500.00
Some of the biggest-selling biological drugs developed during the first phase of the biotechnology revolution in the 1980s, including human growth hormone (hGH) and insulin, are set to lose patent protection in the United States in 2005 and soon after. This opens up a market currently worth over...
Published: Jun 1, 2004 | Price: $1,500.00
Biologics, or biopharmaceuticals, are synthetic or recombinant versions of natural biologic substances, including proteins such as enzymes or antibodies and nucleic acids such as DNA or RNA. Generic products are non-patented chemical and therapeutic equivalents of brand name drugs. However,...
Published: Mar 1, 2004 | Price: $3,500.00
Growth factors are gene products that play important roles in the regulation of cell division and tissue proliferation. Generally, the binding of a growth factor to its receptor initiates or blocks the ability of cells to divide and multiply. Blood and tissue growth factors have become exciting...
Published: Oct 1, 2003 | Price: $2,625.00
Growth factors are gene products that play important roles in the regulation of cell division and tissue proliferation. Generally, the binding of a growth factor to its receptor initiates or, in some cases, blocks the ability of cells to divide and multiply. The nature and mode of action of these...
Published: Feb 1, 2002 | Price: $2,625.00
In the nascent, but rapidly growing field of stem cell therapies, products are a long way from being commercialized. However, the market potential for stem cell therapies products is very large. This report aims to identify those technologies and opportunities in the United States with the greatest...
Published: | Price: {{result.PriceString}}
...
{{ pageDetailsDisplay }}

No reports match your search criteria.